Alpine Immune Sciences to Present at H.C. Wainwright 22nd Annual Global Investment Conference
September 08 2020 - 3:05PM
Business Wire
Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading
clinical-stage immunotherapy company focused on developing
innovative treatments for cancer and autoimmune/inflammatory
diseases, today announced the company will present at the H.C.
Wainwright 22nd Annual Global Investment Conference on Tuesday,
September 15, 2020, at 10:30 a.m. ET/7:30 a.m. PT.
A live webcast of the presentation will be available online in
the investor relations section of the company’s website at
https://ir.alpineimmunesciences.com/events. A replay of the
presentation will be available on the company website for 90 days
following the webcast.
About Alpine Immune Sciences, Inc.
Alpine Immune Sciences, Inc. is committed to leading a new wave
of immune therapeutics. With world-class research and development
capabilities, a highly productive scientific platform, and a proven
management team, Alpine is creating multifunctional immunotherapies
via unique protein engineering technologies to improve patients’
lives. For more information, visit www.alpineimmunesciences.com.
Follow @AlpineImmuneSci on Twitter and LinkedIn.
“Secreted Immunomodulatory Proteins”, “SIP”, “Transmembrane
Immunomodulatory Protein,” “TIP,” “Variant Ig Domain,” “vIgD” and
the Alpine logo are registered trademarks or trademarks of Alpine
Immune Sciences, Inc. in various jurisdictions.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200908005856/en/
Paul Rickey Chief Financial Officer Alpine Immune Sciences, Inc.
206-788-4545 ir@alpineimmunesciences.com
Laurence Watts Managing Director Gilmartin Group, LLC.
619-916-7620 laurence@gilmartinir.com
Alpine Immune Sciences (NASDAQ:ALPN)
Historical Stock Chart
From Apr 2024 to May 2024
Alpine Immune Sciences (NASDAQ:ALPN)
Historical Stock Chart
From May 2023 to May 2024